Clinical Trials · NCT01028924
Effects of Teduglutide on Cardiac Repolarisation and Conduction in Healthy Male and Female Volunteers
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Nycomed
- Enrollment
- 72
- Start date
- Nov 2009
- Locations
- 1 site, Germany
- Primary endpoint
- ECG measurement/assessment to determine the effect of a single dose of teduglutide on cardiac repolarisation (QT, QTc interval).